Clinical Trial: A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07069036) titled 'A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers' on June 30.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-631 in healthy adult volunteers.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: SEP-631

Oral, tablet

OTHER: Placebo

Oral, tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Septerna, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....